Kolexia
Contejean Adrien Hématologie
Contejean Adrien
Hématologie
Centre Hospitalier Annecy Genevois
Epagny Metz-Tessy, France
86 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Tumeurs hématologiques Neutropénie COVID-19 Leucémie myéloïde Lymphomes Maladie grave Sarcomes

Collaborateurs

Voir plus
Bouscary Didier
Bouscary Didier
Hôpital Cochin, Paris, France
Willems Lise
Willems Lise
Hôpital Cochin, Paris, France
Kerneis Solen
Kerneis Solen
Hôpital Bichat-Claude-Bernard, Paris, France
Treluyer Jean-Marc
Treluyer Jean-Marc
Hôpital Necker Enfants Malades, Paris, France

Industries

Voir plus
A+A
64 collaboration(s)
Dernière en 2023
B3TSI
55 collaboration(s)
Dernière en 2023
Janssen
10 collaboration(s)
Dernière en 2023
MSD
7 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study.
Annals of intensive care   06 décembre 2023
Real-World Outcomes Using Front-Line Midostaurine in Combination with Intensive Chemotherapy for Patients Aged ≥ 60 Years Old with FLT3 Mutated Acute Myeloid Leukemia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Real World Use of Azacitidine and Venetoclax in Acute Myeloid Leukemia in Frontline and Relapse/Refractory Settings: A Multicentric Study from French Auraml Group
65th ASH Annual Meeting Abstracts   02 novembre 2023
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes: A Phase I/II, Open-label, Single Arm, Multicenter Dose-finding Study Assess the Safety and Preliminary Efficacy of Oral Azacitidine CC-486 (ONUREG) in Combination With Venetoclax (VENCLYXTO) in Previously Untreated Higher-risk Myelodysplastic Syndromes Ineligible for Allogenic Transplantation
Essai Clinique (BMS)   25 octobre 2023
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
The Journal of antimicrobial chemotherapy   06 septembre 2023
POSTER: AML-454 Real-World Use of Azacitidine (AZA) and Venetoclax (VEN) in Acute Myeloid Leukemia (AML) in Frontline and Relapse/Refractory (R/R) Settings: Multicenter Study From French AURAML Group
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
AML-454 Real-World Use of Azacitidine (AZA) and Venetoclax (VEN) in Acute Myeloid Leukemia (AML) in Frontline and Relapse/Refractory (R/R) Settings: Multicenter Study From French AURAML Group
Proceedings of the Society of Hematologic Oncology 2023 Annual Meeting   01 septembre 2023
Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study.
American journal of hematology   30 août 2023
Survey on infectious disease telephone hotlines in primary care: General practitioners' satisfaction and compliance with advice.
Infectious diseases now   25 août 2023
Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study.
British journal of haematology   04 juillet 2023